2014). Extracorporeal shock wave therapy has been
suggested as an alternative treatment for refractory
shoulder pain due to calcific or noncalcific tendinitis
and may be an alternative to expensive and risky
surgical interventions (Bannuru et al. 2013). Recent
studies show the use of ESWT has been suggested
for the treatment of adhesive capsulitis (Vahdatpour
et al. 2018).
The main purpose of the adhesive capsulitis
treatment is to reduce pain, increase the range of
joint motion and improve the function of the
shoulder. Therapeutic effect of ESWT is to help
revascularization, stimulation, bone reactivation and
healing of connective tissues, which will lower the
pain and improve shoulder joint function.
Shockwave modality uses sound waves of high or
low energy that impart rapid fluctuations of pressure
to tissues. The degree of energy imparted to the
tissues is measured as energy flux density (EFD).
There are many manufacturers of ESWT devices.
Shockwave therapy is usually classified as high,
medium, or low energy, according to the EFD
administered. Although there is no consensus on the
threshold values, a commonly used grouping defines
EFD 0.08 to less than 0.27 mJ/ mm
2
as low energy,
0.28 to less than 0.59 mJ/mm
2
as medium energy, and
more than 0.60 mJ/mm
2
as high energy (Speed 2004).
Several studies have been conducted to observe
the effects of low dose and high dose rESWT in
patients with shoulder pathology. Low dose rESWT
does not reduce pain or improve function compared
with placebo treatment in patients with chronic
tendinitis of the rotator cuff (Kolk et al. 2013).
Systematic review show that high energy fESWT is
more effective than low energy fESWT for
improving pain and shoulder function in chronic
calcific shoulder tendinitis (no similar effects were
seen in noncalcific tendinitis) and can result in the
complete resolution of calcifications (Bannuru et al.
2013). Studies that conducted in adhesive capsulitis
patients reported more effective responses with
higher energy and proper session intervals in patients
with adhesive capsulitis, hematomas as adverse
event was reported in this study (Hussein et al.
2015).
Adverse effects of ESWT were dose dependent,
patients who received high or medium energy ESWT
reported more adverse events than those who
received low energy ESWT. The most commonly
reported adverse events related to ESWT were
temporary increase acute pain and local reactions,
such as swelling, local erythema, petechiae, small
bruises and hematomas. No serious side effects have
been reported (Bannuru et al. 2013).
The aim of this study was to determine the effect
of low energy rESWT in adhesive capsulitis patient
related to shoulder pain, shoulder range of motion,
and function of the shoulder joint.
2 METHODS
The study design was an interventional, experimental
study. A series of single case studies (n=5) was
undertaken with patients shoulder adhesive capsulitis
who visited the outpatient clinic of Physical
Medicine and Rehabilitation Department Hasan
Sadikin Hospital. The participants received oral and
written information about the study and were
informed of the potential risks of treatment. Written
informed consent was obtained from all subjects
before the baseline evaluation. Ethical clearence was
given by the Health Research Ethic Committee
Hasan Sadikin General Hospital.
The inclusion criteria were patients 40 - 65 years
with shoulder pain and restriction in ROM in at least
three directions, (i.e. flexion, abduction, external
rotation, and internal rotation) for a duration of at
least 6 months. Exclusion criteria were history of
shoulder fracture, shoulder dislocation or
subluxation, previous surgery on the shoulder, pre-
rupture tendon or tendon rupture in the shoulder
cancer, glenohumeral or acromioclavicular arthritis,
presence of severe osteoporosis, inflammatory
disorders, pulmonary diseases, bleeding disorders,
pregnancy, any neuromuscular disorders, implanted
pacemaker and unwillingness to participate in the
study.
The rESWT was administered by the same
experienced trained doctor with the EMS Swiss
Dolorclast Smart20
®
(EMS Electro Medical Systems
Corporation, Dallas, TX, USA).
Each patient received four applications of
rESWT, 1 week apart, with 2000 impulses per
session. The air pressure of the device was set to 2.5
bars, frequency of 8 Hz, energy flux density (EFD)
0.11 mJ/mm
2
, and the impulses were applied with a
15 mm applicator.
The shock waves were delivered to two separate
locations per session with the coupling gel. The first
location was applied 1000 impulses in a posterior-to-
anterior direction on the posterior side of the
shoulder joint located beneath the lateral border of
the scapular spine. The second location was applied
remaining 1000 impulses of the total 2000 impulses
per session in an anterior-to-posterior direction of the
anterior shoulder joint, was about one finger breadth
lateral to the coracoid process (Hussein et al. 2015)
(Vahdatpour et al. 2018).